Coloplast A/S
F:CBH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Coloplast A/S
F:CBH
|
DK |
|
N
|
National Vision Holdings Inc
F:7NV
|
US |
|
T
|
T-Mobile US Inc
F:TM5
|
US |
|
P
|
PPL Corp
XMUN:PP9
|
US |
|
M
|
Macquarie Group Ltd
XMUN:4M4
|
AU |
|
ENvue Medical Inc
NASDAQ:FEED
|
US |
|
A
|
Altria Group Inc
BMV:MO
|
US |
|
Primo Brands Corp
F:V76
|
US |
|
R
|
Ryder System Inc
DUS:RYD
|
US |
|
H&R GmbH & Co KgaA
F:2HRA
|
DE |
|
Z
|
Zimmer Biomet Holdings, Inc
XMUN:ZIM
|
US |
|
T
|
Toray Industries Inc
F:TOR1
|
JP |
|
ARE Holdings Inc
F:A19
|
JP |
|
Hang Lung Properties Ltd
F:AOP
|
HK |
Intrinsic Value
Is CBH undervalued or overvalued?
See the intrinsic value estimate for 
Coloplast A/S and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Coloplast A/S Does
Coloplast A/S makes medical devices for people with intimate and chronic care needs. Its main products help with ostomy care, continence care, wound and skin care, and urology. These are usually disposable products such as bags, catheters, and dressings that patients use every day or healthcare professionals use in treatment.
- Headquarters
- Denmark DK
- Employees
- 12 500
- IPO date
- Jan 1, 1983
Coloplast A/S has no economic moat
Customers can choose among rival ostomy and continence products based on fit, and using Coloplast products does not make them more valuable to other users. Its name and range have not been shown to let it charge more for comparable products or keep rivals from competing for the same customers.
Read the full moat analysis
Earnings Waterfall
Coloplast A/S
The intrinsic value for Coloplast A/S (CBH) under the Base Case is hidden EUR.
Compared with the current market price of 6.25 EUR, the stock appears hidden.